The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Obesity, Diabetes, and Increased Cancer Progression
Open accessAbstract
Rates of obesity and diabetes have increased significantly over the past decades and the prevalence is expected to continue to rise further in the coming years. Many observations suggest that obesity and diabetes are associated with an increased risk of developing several types of cancers, including liver, pancreatic, endometrial, colorectal, and post-menopausal breast cancer. The path towards developing obesity and diabetes is affected by multiple factors, including adipokines, inflammatory cytokines, growth hormones, insulin resistance, and hyperlipidemia. The metabolic abnormalities associated with changes in the levels of these factors in obesity and diabetes have the potential to significantly contribute to the development and progression of cancer through the regulation of distinct signaling pathways. Here, we highlight the cellular and molecular pathways that constitute the links between obesity, diabetes, cancer risk and mortality. This includes a description of the existing evidence supporting the obesity-driven morphological and functional alternations of cancer cells and adipocytes through complex interactions within the tumor microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Pearson-Stuttard, J., Zhou, B., Kontis, V., Bentham, J., Gunter, M. J., & Ezzati, M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30150-5 · Cited by 307
RetractedPearson-Stuttard, J., Zhou, B., Kontis, V., Bentham, J., Gunter, M. J., & Ezzati, M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30366-2 · Cited by 265
RetractedThe oncogenic roles of 27‑hydroxycholesterol in glioblastoma
Liu, L., Li, M., Xing, Y., Wang, X., & Wang, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.10690 · Cited by 24
RetractedPositional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237
Self-citationAdipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
Muz, B., de la Puente, P., Azab, F., & Azab, A. K. (2015) · Hypoxia · doi:10.2147/hp.s93413 · Cited by 2,066
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Jing, X., Yang, F., Shao, C., Wei, K., Xie, M., Shen, H., & Shu, Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1089-9 · Cited by 2,054
Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones
Payne, A. H., & Hales, D. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0030 · Cited by 1,766
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764 · cited 2×
“These multiple metabolic substrates have been implicated as risk factors for cancer incidence and mortality [9-11].”
BackgroundOuchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,737
Role of tumor microenvironment in tumorigenesis
Wang, M., Zhao, J., Zhang, L., Wei, F., Lian, Y., Wu, Y., Gong, Z., Zhang, S., Zhou, J., Cao, K., et al. (2017) · Journal of Cancer · doi:10.7150/jca.17648 · Cited by 1,404
Lipid metabolic reprogramming in cancer cells
Beloribi-Djefaflia, S., Vasseur, S., & Guillaumond, F. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.49 · Cited by 1,398
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism
Berg, A. H., Combs, T. P., & Scherer, P. E. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00524-0 · Cited by 1,213
Self-citationInflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy
Henke, E., Nandigama, R., & Ergün, S. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00160 · Cited by 1,142
Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion
Dirat, B., Bochet, L., Dabek, M., Daviaud, D., Dauvillier, S., Majed, B., Wang, Y. Y., Meulle, A., Salles, B., Le Gonidec, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3323 · Cited by 1,134
Stern, J. H., Rutkowski, J. M., & Scherer, P. E. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.011 · Cited by 1,031
Self-citationNew Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985 · cited 2×
“Insulin resistance Insulin is a hormone that is produced by β-cells in the pancreas and is primarily responsible for stimulating glucose uptake and storage to regulate glucose levels in blood [51].”
BackgroundBeta Cell Dysfunction and Insulin Resistance
Cerf, M. E. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00037 · Cited by 964 · cited 3×
“Hyperinsulinemia Hyperinsulinemia is characterized by chronically elevated insulin in the blood due to dysregulated insulin secretion and/or clearance [93].”
BackgroundUlrich, T. A., de Juan Pardo, E. M., & Kumar, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4859 · Cited by 901
27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
Nelson, E. R., Wardell, S. E., Jasper, J. S., Park, S., Suchindran, S., Howe, M. K., Carver, N. J., Pillai, R. V., Sullivan, P. M., Sondhi, V., et al. (2013) · Science · doi:10.1126/science.1241908 · Cited by 839
Obesity and diabetes: the increased risk of cancer and cancer-related mortality
Gallagher, E. J., & LeRoith, D. (2015) · Physiological Reviews · doi:10.1152/physrev.00030.2014 · Cited by 806
Obesity and cancer—mechanisms underlying tumour progression and recurrence
Park, J., Morley, T. S., Kim, M., Clegg, D. J., & Scherer, P. E. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.94 · Cited by 790
Self-citationOuchi, N., Kobayashi, H., Kihara, S., Kumada, M., Sato, K., Inoue, T., Funahashi, T., & Walsh, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310389200 · Cited by 759 · cited 2×
“Activation of several metabolic signaling pathways including IKKβ/NF-κB and c-Jun N-terminal kinase (JNK) pathways by excess nutrients leads to initiation of obesity-associated inflammation and a subsequent chronic low-grade inflammatory response (Fig.”
BackgroundIntracellular signalling pathways activated by leptin
Frühbeck, G. (. (2006) · Deposito Adademico Digital Universidad De Navarra (University of Navarra) · Cited by 745
Intracellular signalling pathways activated by leptin
Frühbeck, G. (2006) · Biochemical Journal · doi:10.1042/bj20051578 · Cited by 696
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies
Ben, Q., Xu, M., Ning, X., Liu, J., Hong, S., Huang, W., Zhang, H., & Li, Z. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.003 · Cited by 685
Targeting adipose tissue in the treatment of obesity-associated diabetes
Kusminski, C. M., Bickel, P. E., & Scherer, P. E. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.75 · Cited by 678
Self-citationAltered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome
Kahn, C. R., Wang, G., & Lee, K. Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129187 · Cited by 661
Diabetic Dyslipidemia: Causes and Consequences
Goldberg, I. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.965 · Cited by 643
The Role of Adiponectin in Cancer: A Review of Current Evidence
Dalamaga, M., Diakopoulos, K. N., & Mantzoros, C. S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1015 · Cited by 640
Diabetic Cardiomyopathy: The Search for a Unifying Hypothesis
Poornima, I. G., Parikh, P., & Shannon, R. P. (2006) · Circulation Research · doi:10.1161/01.res.0000207406.94146.c2 · Cited by 571
Adipokines as novel biomarkers and regulators of the metabolic syndrome
Deng, Y., & Scherer, P. E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05875.x · Cited by 558
Self-citationAssociation of serum adiponectin levels with breast cancer risk.
Miyoshi, Y., Funahashi, T., Kihara, S., Taguchi, T., Tamaki, Y., Matsuzawa, Y., & Noguchi, S. (2003) · PubMed · Cited by 503
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Bodmer, M., Meier, C., Krähenbühl, S., Jick, S. S., & Meier, C. R. (2010) · Diabetes Care · doi:10.2337/dc09-1791 · Cited by 466
Cancer-associated adipocytes: key players in breast cancer progression
Wu, Q., Li, B., Li, Z., Li, J., Sun, S., & Sun, S. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0778-6 · Cited by 462 · cited 3×
“Adipocytes also acquire phenotypic changes through multiple bioactive factors released by surrounding cancer cells, resulting in significantly increased secretion of many metabolic substrates [30,78,87].”
BackgroundCancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors
Lengyel, E., Makowski, L., DiGiovanni, J., & Kolonin, M. G. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.03.004 · Cited by 424
Balaban, S., Shearer, R. F., Lee, L. S., van Geldermalsen, M., Schreuder, M., Shtein, H. C., Cairns, R., Thomas, K. C., Fazakerley, D. J., Grewal, T., et al. (2017) · Cancer & Metabolism · doi:10.1186/s40170-016-0163-7 · Cited by 416
The proliferating role of insulin and insulin-like growth factors in cancer
Gallagher, E. J., & LeRoith, D. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.06.007 · Cited by 380
Adiponectin, Leptin and Cardiovascular Disorders
Zhao, S., Kusminski, C. M., & Scherer, P. E. (2021) · Circulation Research · doi:10.1161/circresaha.120.314458 · Cited by 373
Self-citationReview: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications
Lega, I. C., & Lipscombe, L. L. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz014 · Cited by 364
Diabetes and breast cancer risk: A meta-analysis
Boyle, P., Boniol, M., Koechlin, A., Robertson, C., Valentini, F., Coppens, K., Fairley, L.-L., Boniol, M., Zheng, T., Zhang, Y., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.414 · Cited by 358
Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders
Lehr, S., Hartwig, S., & Sell, H. (2012) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201100052 · Cited by 352
Saraei, P., Asadi, I., Kakar, M. A., & Moradi-Kor, N. (2019) · Cancer Management and Research · doi:10.2147/cmar.s200059 · Cited by 350
Paracrine and Endocrine Effects of Adipose Tissue on Cancer Development and Progression
Park, J., Euhus, D. M., & Scherer, P. E. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0030 · Cited by 348
Self-citationObesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation
Divella, R., De Luca, R., Abbate, I., Naglieri, E., & Daniele, A. (2016) · Journal of Cancer · doi:10.7150/jca.16884 · Cited by 335
beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran, V., Lee, S. H., Inge, L. J., Guo, L., Goldbeck, C., Garrett, E. N., Wiesmann, M., García, P. D., Fuller, J. H., Chan, V. W.-F., et al. (2003) · PubMed · Cited by 334
Interaction of tumor cells with the microenvironment
Ungefroren, H., Sebens, S., Seidl, D., Lehnert, H., & Hass, R. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-18 · Cited by 333
Desbois-Mouthon, C., Cadoret, A., Blivet-Van Eggelpoël, M.-J., Bertrand, F., Cherqui, G., Perret, C., & Capeau, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204064 · Cited by 321
Liang, J., & Shang, Y. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183708 · Cited by 314
Ceramide glycosylation potentiates cellular multidrug resistance
LIU, Y., HAN, T., GIULIANO, A. E., & CABOT, M. C. (2001) · The FASEB Journal · doi:10.1096/fj.00-0223com · Cited by 303
Insulin–PI3K signalling: an evolutionarily insulated metabolic driver of cancer
Hopkins, B. D., Goncalves, M. D., & Cantley, L. C. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0329-9 · Cited by 288
Novosyadlyy, R., Lann, D. E., Vijayakumar, A., Rowzee, A., Lazzarino, D. A., Fierz, Y., Carboni, J. M., Gottardis, M. M., Pennisi, P. A., Molinolo, A. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2141 · Cited by 282
Mollinedo, F., & Gajate, C. (2020) · Journal of Lipid Research · doi:10.1194/jlr.tr119000439 · Cited by 279
Diabetes and cancer: two diseases with obesity as a common risk factor
Garg, S. K., Maurer, H., Reed, K., & Selagamsetty, R. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12124 · Cited by 275
Ye, L.-Y., Chen, W., Bai, X.-L., Xu, X.-Y., Zhang, Q., Xia, X.-F., Sun, X., Li, G.-G., Hu, Q.-D., Fu, Q.-H., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0977 · Cited by 275
Metformin as an Anticancer Agent
Vancura, A., Bu, P., Bhagwat, M., Zeng, J., & Vancurova, I. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.07.006 · Cited by 274
(2003) · PubMed · Cited by 272
Obesity and Breast Cancer: Role of Leptin
Sánchez-Jiménez, F., Pérez-Pérez, A., de la Cruz-Merino, L., & Sánchez-Margalet, V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00596 · Cited by 268
Obesity, Type 2 Diabetes, and Cancer Risk
Scully, T., Ettela, A., LeRoith, D., & Gallagher, E. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615375 · Cited by 256
Akt-Dependent and -Independent Survival Signaling Pathways Utilized by Insulin-Like Growth Factor I
Kulik, G., & Weber, M. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6711 · Cited by 241
Adiponectin, Obesity, and Cancer: Clash of the Bigwigs in Health and Disease
Parida, S., Siddharth, S., & Sharma, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102519 · Cited by 238
Pillon, N. J., Loos, R. J. F., Marshall, S. M., & Zierath, J. R. (2021) · Cell · doi:10.1016/j.cell.2021.02.012 · Cited by 234
Aromatase, breast cancer and obesity: a complex interaction
Bulun, S. E., Chen, D., Moy, I., Brooks, D. C., & Zhao, H. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.10.003 · Cited by 224
Adiponectin Represses Colon Cancer Cell Proliferation via AdipoR1- and -R2-Mediated AMPK Activation
Kim, A. Y., Lee, Y. S., Kim, K. H., Lee, J. H., Lee, H. K., Jang, S.-H., Kim, S.-E., Lee, G. Y., Lee, J.-W., Jung, S.-A., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0498 · Cited by 214
Saxena, N. K., Taliaferro-Smith, L., Knight, B. B., Merlin, D., Anania, F. A., O'Regan, R. M., & Sharma, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1952 · Cited by 213
He, X., Esteva, F. J., Ensor, J., Hortobagyi, G. N., Lee, M.-H., & Yeung, S.-C. J. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr534 · Cited by 207
The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
Lee, J. H., Kim, T. I., Jeon, S. M., Hong, S. P., Cheon, J. H., & Kim, W. H. (2012) · International Journal of Cancer · doi:10.1002/ijc.26421 · Cited by 204
Chang, C.-H., Lin, J.-W., Wu, L.-C., Lai, M.-S., Chuang, L.-M., & Chan, K. A. (2012) · Hepatology · doi:10.1002/hep.25509 · Cited by 193
Tsilidis, K. K., Capothanassi, D., Allen, N. E., Rizos, E. C., Lopez, D. S., van Veldhoven, K., Sacerdote, C., Ashby, D., Vineis, P., Tzoulaki, I., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0584 · Cited by 190
Contribution of adipose tissue to development of cancer
Cozzo, A. J., Fuller, A. M., & Makowski, L. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170008 · Cited by 188
Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment
Suh, S., & Kim, K.-W. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0177 · Cited by 185
Simpson, A., Petnga, W., Macaulay, V. M., Weyer-Czernilofsky, U., & Bogenrieder, T. (2017) · Targeted Oncology · doi:10.1007/s11523-017-0514-5 · Cited by 183
Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
Chocarro-Calvo, A., García-Martínez, J. M., Ardila-González, S., De la Vieja, A., & García-Jiménez, C. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.11.022 · Cited by 179
Mechanism of Metformin: A Tale of Two Sites
Song, R. (2016) · Diabetes Care · doi:10.2337/dci15-0013 · Cited by 178
Taliaferro-Smith, L., Nagalingam, A., Zhong, D., Zhou, W., Saxena, N. K., & Sharma, D. (2009) · Oncogene · doi:10.1038/onc.2009.129 · Cited by 172
Zhang, Y., Moerkens, M., Ramaiahgari, S., de Bont, H., Price, L., Meerman, J., & van de Water, B. (2011) · Breast Cancer Research · doi:10.1186/bcr2883 · Cited by 171
Di Marzio, D. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s993 · Cited by 169
Cancer-associated adipocytes: emerging supporters in breast cancer
Zhao, C., Wu, M., Zeng, N., Xiong, M., Hu, W., Lv, W., Yi, Y., Zhang, Q., & Wu, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01666-z · Cited by 169
The Links Between Insulin Resistance, Diabetes, and Cancer
Orgel, E., & Mittelman, S. D. (2013) · Current Diabetes Reports · doi:10.1007/s11892-012-0356-6 · Cited by 162
Stevens, R. J., Ali, R., Bankhead, C. R., Bethel, M. A., Cairns, B. J., Camisasca, R. P., Crowe, F. L., Farmer, A. J., Harrison, S., Hirst, J. A., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2653-7 · Cited by 161
The potential role of leptin in tumor invasion and metastasis
Ray, A., & Cleary, M. P. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.11.002 · Cited by 158
Metformin Targets Multiple Signaling Pathways in Cancer
Lei, Y., Yi, Y., Liu, Y., Liu, X., Keller, E. T., Qian, C.-N., Zhang, J., & Lu, Y. (2017) · Chinese Journal of Cancer · doi:10.1186/s40880-017-0184-9 · Cited by 152
A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose
García-Jiménez, C., García-Martínez, J. M., Chocarro-Calvo, A., & De la Vieja, A. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0152 · Cited by 151 · cited 1×
“Metabolic disturbances in type 2 diabetes mellitus (T2DM), such as hyperinsulinemia and dyslipidemia, have been proposed as causal links between diabetes and cancer [14,15].”
BackgroundChandrasekar, B., Boylston, W. H., Venkatachalam, K., Webster, N. J. G., Prabhu, S. D., & Valente, A. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804236200 · Cited by 151
Thiazolidinediones as anti-cancer agents.
Blanquicett, C., Roman, J., & Hart, C. M. (2008) · PubMed · Cited by 146
Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo
Landskroner-Eiger, S., Qian, B., Muise, E. S., Nawrocki, A. R., Berger, J. P., Fine, E. J., Koba, W., Deng, Y., Pollard, J. W., & Scherer, P. E. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2649 · Cited by 145
Self-citationAdiponectin as Link Factor between Adipose Tissue and Cancer
Zazzo, E. D., Polito, R., Bartollino, S., Nigro, E., Porcile, C., Bianco, A., Daniele, A., & Moncharmont, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040839 · Cited by 144
Challenges and Perspectives in the Treatment of Diabetes Associated Breast Cancer
Samuel, S. M., Varghese, E., Varghese, S., & Büsselberg, D. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.08.004 · Cited by 141
Guaita‐Esteruelas, S., Bosquet, A., Saavedra-García, P., Gumà, J., Girona, J., Lam, E. W. ‐., Amillano, K., Borràs, J., & Masana, L. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22485 · Cited by 141
Adipocyte–Tumor Cell Metabolic Crosstalk in Breast Cancer
Hoy, A. J., Balaban, S., & Saunders, D. N. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.02.009 · Cited by 139
Anticancer mechanisms of metformin: A review of the current evidence
Zhao, B., Luo, J., Yu, T., Zhou, L., Lv, H., & Shang, P. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117717 · Cited by 131
Stanisavljević, J., Loubat‐Casanovas, J., Herrera, M., Luque, T., Peña, R., Lluch, A. M., Albanell, J., Bonilla, F., Rovira, A., Peña, C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1903 · Cited by 129
Romero-López, M., Trinh, A. L., Sobrino, A., Hatch, M. M. S., Keating, M. T., Fimbres, C., Lewis, D. E., Gershon, P. D., Botvinick, E. L., Digman, M., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.034 · Cited by 125
Gong, C., Yu, X., Zhang, W., Han, L., Wang, R., Wang, Y., Gao, S., & Yuan, Y. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00805-8 · Cited by 121
Obesity, metabolism and the microenvironment: Links to cancer
Makowski, L., Sundaram, S., & Johnson, A. (2013) · Journal of Carcinogenesis · doi:10.4103/1477-3163.119606 · Cited by 115
Wei, L., Li, K., Pang, X., Guo, B., Su, M., Huang, Y., Wang, N., Ji, F., Zhong, C., Yang, J., et al. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0446-4 · Cited by 115
Huang, J., Durán, Á., Reina‐Campos, M., Valencia, T., Castilla, E. A., Müller, T. D., Tschöp, M. H., Moscat, J., & Díaz-Meco, M. T. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.001 · Cited by 114
Goodwin, P. J., Ennis, M., Bahl, M., Fantus, I. G., Pritchard, K. I., Trudeau, M., Koo, J., & Hood, N. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0019-0 · Cited by 108
Cancer risks in thiazolidinedione users compared to other anti-diabetic agents
Koro, C., Barrett, S., & Qizilbash, N. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1352 · Cited by 107
Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer
Kimbung, S., Chang, C., Bendahl, P., Dubois, L. G., Thompson, J. W., McDonnell, D. P., & Borgquist, S. (2017) · Endocrine Related Cancer · doi:10.1530/erc-16-0533 · Cited by 100
Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer
Lambe, M. P., Wigertz, A., Garmo, H., Walldius, G., Jungner, I., & Hammar, N. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9794-8 · Cited by 99
Rosiglitazone and Risk of Cancer
Monami, M., Lamanna, C., Marchionni, N., & Mannucci, E. (2008) · Diabetes Care · doi:10.2337/dc07-2308 · Cited by 97
He, K., Hu, H., Ye, S., Wang, H., Cui, R., & Yi, L. (2019) · Scientific Reports · doi:10.1038/s41598-018-38285-w · Cited by 97
Kheshtchin, N., Arab, S., Ajami, M., Mirzaei, R., Ashourpour, M., Mousavi-Niri, N., Khosravianfar, N., Jadidi‐Niaragh, F., Namdar, A., Noorbakhsh, F., et al. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1879-5 · Cited by 95
Gallagher, E. J., Fierz, Y., Vijayakumar, A., Haddad, N., Yakar, S., & LeRoith, D. (2011) · Oncogene · doi:10.1038/onc.2011.495 · Cited by 90
Circulating adiponectin levels and the risk of breast cancer
Ye, J., Jia, J., Dong, S., Zhang, C., Yu, S., Li, L., Mao, C., Wang, D., Chen, J., & Yuan, G. (2013) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328364f293 · Cited by 83
Chen, D., Reierstad, S., Lin, Z., Lü, M., Brooks, C., Li, N., Innes, J. E., & Bulun, S. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4751 · Cited by 80
Leptin and cancer: from cancer stem cells to metastasis
Park, J., & Scherer, P. E. (2011) · Endocrine Related Cancer · doi:10.1530/erc-11-0163 · Cited by 77
Self-citationPham, D., & Park, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031444 · Cited by 77
Guillemot‐Legris, O., Mutemberezi, V., Cani, P. D., & Muccioli, G. G. (2016) · Scientific Reports · doi:10.1038/srep19694 · Cited by 70
27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator
He, S., & Nelson, E. R. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.07.014 · Cited by 68
Jiang, Z., Hsu, J. L., Li, Y., Hortobágyi, G. N., & Hung, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01197 · Cited by 67
Ferruzzi, J., Sun, M., Gkousioudi, A., Pilvar, A., Roblyer, D. M., Zhang, Y., & Zaman, M. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-50268-z · Cited by 64
Le, C., Bennasroune, A., Langlois, B., Salesse, S., Boulagnon‐Rombi, C., Morjani, H., Dedieu, S., & Appert-Collin, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00527 · Cited by 61
Jiang, J., Fan, Y., Zhang, W., Shen, Y., Liu, T., Yao, M., Gu, J., Tu, H., & Gan, Y. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.27420 · Cited by 53
Xu, Y., Tan, M., Tian, X., Zhang, J., Zhang, J., Chen, J., Xu, W., & Sheng, H. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10855 · Cited by 41
Arvind, A., Memel, Z. N., Philpotts, L. L., Zheng, H., Corey, K. E., & Simon, T. G. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154780 · Cited by 41
Wang, W., Lai, H.-Y., Zhang, F., Shen, W., Chu, P., Liang, H., Liu, Y., & Wang, J. (2021) · JCI Insight · doi:10.1172/jci.insight.135438 · Cited by 40
Du, R., Lin, L., Cheng, D., Xu, Y. H., Xu, M., Chen, Y., Wang, W., Bi, Y., Li, D., & Lu, J. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2961 · Cited by 35
Peng, C., Sun, Z., Li, O., Guo, C., Yi, W., Tan, Z., & Jiang, B. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4807 · Cited by 31
Adult weight gain accelerates the onset of breast cancer
Azrad, M., Blair, C. K., Rock, C. L., Sedjo, R. L., Wolin, K. Y., & Demark‐Wahnefried, W. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05268-y · Cited by 29
Chen, D., Reierstad, S., Fang, F., & Bulun, S. E. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0368 · Cited by 28
Leptin as a Potential Target for Estrogen Receptor-Positive Breast Cancer
Yom, C. K., Lee, K., Han, W., Kim, S., Kim, H. S., Moon, B.-I., Jeong, K.-Y., Im, S., & Noh, D. (2013) · Journal of Breast Cancer · doi:10.4048/jbc.2013.16.2.138 · Cited by 27
Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer
Lipsey, C. C., Harbuzariu, A., Robey, R. W., Huff, L. M., Gottesman, M. M., & Gonzalez-Perez, R. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113794 · Cited by 27
Mukhopadhyay, K. D., Liu, Z., Bandyopadhyay, A. M., Kirma, N. B., TEKMAL, R. R., Wang, S., & Sun, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121136 · Cited by 26
Kimbung, S., Inasu, M., Stålhammar, T., Nodin, B., Elebro, K., Tryggvadottir, H., Rödström, M. Y., Jirström, K., Isaksson, K., Jernström, H., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01347-x · Cited by 23
Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies
Fong, D., Christensen, C. T., & Chan, M. M.-Y. (2021) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892816666210208232251 · Cited by 20
Behrouzi, B., Zokaasadi, M., Mohagheghi, M. A., Emami, A., & Sadighi, S. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.2.611 · Cited by 5
Cited by
Colorectal Cancer: Epidemiology, Risk Factors, and Prevention
Roshandel, G., Ghasemi-Kebria, F., & Malekzadeh, R. (2024) · Cancers · doi:10.3390/cancers16081530 · Cited by 431
Metabolites as signalling molecules
Baker, S. A., & Rutter, J. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00572-w · Cited by 368
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Tomuleasa, C., Tigu, A.-B., Munteanu, R., Moldovan, C.-S., Kegyes, D., Onaciu, A., Gulei, D., Ghiaur, G., Einsele, H., & Croce, C. M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01899-w · Cited by 260
The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer
Ibrahim, S. S., Ibrahim, R. S., Arabi, B., Brockmueller, A., Shakibaei, M., & Büsselberg, D. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10192-9 · Cited by 56
Metadata
- Authors
- Kim, D.-S., & Scherer, P. E.
- Venue
- Diabetes & Metabolism Journal
- Publisher
- Korean Diabetes Association
- Published
- 2021-11-30
- Volume
- 45
- Issue
- 6
- Pages
- 799-812
- ISSN
- 2233-6079 (ISSN-L)
- 2233-6087
- OpenAlex
- W3216657747
- Cited by
- 302
- References
- 136
- FWCI
- 12.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.